Atom Investors LP Catalyst Pharmaceuticals, Inc. Transaction History

Atom Investors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$3.67 - $5.7 $3.72 Million - $5.77 Million	-1,012,355 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.89 - $7.43 $1.1 Million - $2.11 Million	283,356 Added 38.87%	1,012,355 $5.38 Million
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $1.97 Million - $4.45 Million	728,999 New	728,999 $2.8 Million

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.